are they going to stop making tirzepatide The recent announcement that has been removed from the FDA's drug shortage list is good news for people looking for effective weight loss solutions. But, it could mean the compounded versions Drugmakers can keep making off-brand

Over the last two years, the surging demand for GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) has Over the last two years, the surging demand for GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) has created both clinical and supply chain challenges.

Semaglutide works by reducing hunger and slowing digestion, but certain foods can trigger nausea, bloating, and reduced effectiveness

Schedule your consultation today

This case underscores that standard fasting protocols may not ensure gastric emptying in patients on GLP-1 RA therapy, particularly during medication up-titration or in those with coexisting gastrointestinal motility disorders

A large-scale study suggests that GLP-1 drugs could have unexpected mental health benefits, including lower risks of depression, anxiety, and substance use.

In fact it does not even address the disease